Hospital Acquired Infections Therapeutic Market Size to Reach Worth $12.52 Billion By 2028 | CAGR: 2.3%: Polaris Market Research

News provided by

Sep 08, 2021, 09:21 ET

NEW YORK, Sept. 8, 2021 /PRNewswire/ -- The global hospital acquired infections therapeutic market size anticipated to reach USD 12.52 billion by 2028. according to a new study by Polaris Market Research. according to a new study conducted by Polaris Market Research. the market is anticipated to register a CAGR 2.3% from 2021-2028. The increasing geriatric population, rise in operating room procedures, and changing reimbursement policies are among the key factors driving the market growth. In addition to this, the rise in government initiatives for better healthcare management, increasing healthcare expenditure, and availability of advance medical facilities are working in the favor of the market. Moreover, the increasing launch of drugs specifically developing for the hospital acquired infections coupled with rising investments in R&D initiatives further complementing the market growth.

Request For A Sample Report: https://www.polarismarketresearch.com/industry-analysis/hospital-acquired-infections-therapeutic-market/request-for-sample

Key Highlights of Hospital Acquired Infections Therapeutic Market

Based on drug class, the antibacterial drugs segment contributed the largest revenue share, owing to increasing cases of hospital acquired infections (HAIs) caused due to bacteria that can be treated with antibacterial drugs.
In terms of infection type, the surgical site infections (SSIs) segment dominated the HAIs therapeutics and is expected to continue the same trend during the forecast period. An increasing rate of surgical procedures and increasing cases of SSIs are driving the segment's growth.
The government is launching initiatives to establish patient safety networks, and quality-focused organizations are collaborating to improve infection control and reduce the number of patients who contract these conditions.
Increasing accessibility of novel hospital-acquired infection therapeutics in major countries of the Europe region as a result of the rise in presence of key market players is expected to support regional growth.

Regional Developments

The market in North America is projected to dominate the global hospital acquired infections therapeutic market, on account of the growing geriatric population and increasing cases of chronic diseases. Additionally, governments of developed countries from this region are funding heavily research and development programs to contain hospital-acquired infections. On the other side, the Asia Pacific market is anticipated to emerge as the fastest-growing regional market for hospital infection therapeutics, owing to the improving healthcare infrastructure coupled with rising healthcare expenditure.

Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At: https://www.polarismarketresearch.com/industry-analysis/hospital-acquired-infections-therapeutic-market/speak-to-analyst

Competitive Outlook

Leading players operating in the hospital acquired infections therapeutic market are engaged in large-scale R&D activities for the development of HAI treatment. Additionally, market players are also adopting strategies such as collaborations, product development, and regional expansions to gain a competitive edge in the market. Some of the prominent players include Merck, Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc., Bayer AG, AbbVie Inc., F. Hoffmann-La Roche Ltd, Daiichi Sankyo Company, Limited and Allergan Plc

Target Audience

Supply Side: Pharmaceutical Company
Demand Side: Hospital
Regulatory Side: World Health Organization

Polaris Market Research has segmented the hospital acquired infections therapeutic market report on the basis of drug class, infection type, and region:

Hospital Acquired Infections Therapeutic, Drug Class Outlook (Revenue – USD Million, 2016 – 2028)

Antibacterial Drugs

Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
Others

Antiviral Drugs
Antifungal Drugs

Hospital Acquired Infections Therapeutic, Infection Type Outlook (Revenue – USD Million, 2016 – 2028)

Urinary Tract Infections
Ventilator-associated Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections

Hospital Acquired Infections Therapeutic, by Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

U.S.
Canada

Europe

France
Germany
UK
Italy
Spain
Netherlands
Austria

Asia Pacific

China
India
Japan
Malaysia
South Korea
Indonesia

Central & South America

Mexico
Brazil
Argentina

Middle East & Africa

UAE
Saudi Arabia
Israel
South Africa

Buy Now this Premium Report to Grow your Business @ https://www.polarismarketresearch.com/checkouts/8331

Find more research reports on Healthcare by PMR

Hospital Outsourcing Market Share, Size, Trends, Industry Analysis Report, By Service (Healthcare IT, Clinical services, Business services, Transportation services, Others); By Type (Public, Private); By Regions; Segment Forecast, 2020 - 2027

Sternal Closure Systems Market Share, Size, Trends, Industry Analysis Report, By Product (Closure Devices, Bone Cement), By Material (Titanium, PEEK, Stainless Steel), By Procedure (Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy), By Region; Segment Forecast, 2021 – 2028

Medical Devices Reimbursement Market Share, Size, Trends, Industry Analysis Report, By Payer (Public, Private); By Healthcare Setting (Hospitals, Outpatient Facilities, Others); By Regions; Segment Forecast, 2021 - 2028

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-917-985-9017
Email: [email protected]
Web: https://www.polarismarketresearch.com/
Follow US: LinkedIn | twitter